Brief: Hemogenyx Pharmaceuticals Announces Submission Of IND For Hemo-Car-T

Hemogenyx Pharmaceuticals

09/05/2023 07:56

May 9 (Reuters) - Hemogenyx Pharmaceuticals PLC  HEMO.L :
    * HEMOGENYX PHARMA PLC  - SUBMISSION OF IND FOR HEMO-CAR-T
    * HEMOGENYX PHARMACEUTICALS- IND APPLICATION SEEKING AUTHORIZATION FROM U.S.
FDA
FOR PHASE I CLINICAL TRIAL OF CHIMERIC ANTIGEN RECEPTOR T-CELLS

Source text for Eikon:  ID:nRSI6705Ya 
Further company coverage:  HEMO.L 

 ((Reuters.Briefs@thomsonreuters.com;))